MedTrace Logo

Menstrual Cycle Maintenance and Quality of Life: A Prospective Study

NCT00589654 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 810

Last updated 2026-01-07

No results posted yet for this study

Summary

Very little is known about the incidence, onset, time course, and symptomatology of premature menopause induced by breast cancer therapy. No prospective study exists. The purpose of the present study is to identify determinants of treatment-related amenorrhea nad its effect on quality of life in a cohort of youg breast cancer patients.

Conditions

Interventions

OTHER

Questionnaire

Data collection instruments will be obtained at baseline and every six months. Follow-up will range between 26-42 months for participants.

Sponsors & Collaborators

Principal Investigators

  • Tracy-Ann Moo, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-12-31
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00589654 on ClinicalTrials.gov